18 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
9 Apr 24
Results of Operations and Financial Condition
8:30am
that featured a diverse study population, closely representative of the demographics of women across the US. 1 References: 1. Nelson AL, Kaunitz AM, Kroll R
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
off Territory
Synchronization Reports
Interaction by Date and Time
Field Action Requests
Account Demographics
Target/Non-Target
Account Type
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
24 May 22
Departure of Directors or Certain Officers
7:30am
, closely representative of the demographics of women across the US .. 1 References: 1 .. Nelson AL, Kaunitz AM, Kroll R, et al. Efficacy, safety
8-K
EX-99.1
vcgntue jiyjn7wa
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
akz7v89gm7d7o7om
7 Dec 20
Other Events
4:30pm
8-K
EX-99.1
olyqw7bhr0lwo s2tuj
28 Jun 19
Other Events
8:00am
8-K
EX-99.2
zrg4mnlni5f9z5h fkmt
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2ndĀ Annual FormulationĀ & Drug Delivery USA Congress
4:31pm
10-K
dvjqudbkuq8di
26 Mar 15
Annual report
12:00am
8-K
EX-99.1
h3u6x yf7s4
26 Jun 14
Regulation FD Disclosure
12:00am
424B4
97z 9khgpj2ef
23 May 14
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next